Results 151 to 160 of about 67,511,782 (172)

Correction to "Kimura Disease With Eosinophilic Granulomatosis With Polyangiitis Successfully Treated by Mepolizumab". [PDF]

Clin Case Rep
europepmc   +1 more source

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis [PDF]

New England Journal of Medicine, 2017
Eosinophilic granulomatosis with polyangiitis is an eosinophilic vasculitis. Mepolizumab, an anti-interleukin-5 monoclonal antibody, reduces blood eosinophil counts and may have value in the treatment of eosinophilic granulomatosis with ...
Praveen Akuthota, Peter A Merkel, Peter F Weller   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss)

Rheumatology, 2022
Loïc Guillevin, Benjamin Terrier, Silvia Sartorelli   +2 more
exaly  

Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis

Expert Opinion on Pharmacotherapy, 2023
Alvise Berti
exaly  

Benralizumab in eosinophilic granulomatosis with polyangiitis complicated by sepsis

Clinical Immunology, 2021
Jakob Nilsson, Alain Rudiger, Antonios Kolios   +2 more
exaly  

Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab

Journal of Allergy and Clinical Immunology: Global, 2022
Koichiro Asano, Naoki Hayama
exaly  

American Journal of Respiratory and Critical Care Medicine

American Journal of Respiratory and Critical Care Medicine, 2020
Mark A. Little, Benjamin Terrier
exaly  

Cardiac manifestations of eosinophilic granulomatosis with polyangiitis from a single-center cohort in China: clinical features and associated factors

Therapeutic Advances in Chronic Disease, 2021
Fengchun Zhang, Xiaofeng Zeng, Suying Liu   +2 more
exaly